Medivation has been exploding higher, and the bulls are looking for more.
optionMONSTER's Heat Seeker tracking system detected the purchase of more than 5,000 March 70 calls, most of which priced for $4.30. Volume was almost 4 times open interest in the strike.
The trade reflects a belief that the high-flying drug developer will continue to rally over the next month. The long calls lock in an entry price for buying the stock and imply that it will close at $74.30 or higher on expiration.
MDVN fell 1.14 percent to $67.93 on Friday but has more than quadrupled in the last six months. It's been rallying on positive test results for its MDV3100 treatment for prostate cancer.
The market also seems to consider the company a potential takeover target. Other drug developers, including Pharmacyclics and Idenix Pharmaceuticals, have been surging as well, especially after Bristol-Myers Squibb paid a huge premium for Inhibitex last month.
Overall option volume in MDVN was twice the average amount on Friday, with calls outnumbering puts by 21 to 1, according to the Heat Seeker.
More From optionMONSTER
European stocks rose for a third straight session on Monday and the euro edged up, as Greek polls showed growing …



1 comment